NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
03/11/2026
Back to search
Official data from USPTO
ONCOKDM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
03/31/2026
Trademark type
Combined
Nice classes
9, 42, 44
Filing date
03/01/2019
Registration date
11/05/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/11/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
707
Official register
Principal Register
Drawing code
3
Owner type
33
Owner location
Gosselies, BE
Examiner
MAI, TINA HSIN
Current location
Historical data usage
Mark description
The mark consists of a logo (a kind of rosace) in white and two colors of blue (the left of the logo is colored in light blue dots, dark blue and white, while the right side is in white and dark blue), and the wording "OncoKDM", where the first letter "O" is in uppercase, and the letters "KDM" are uppercase as well; these three letters are in light blue while the "Onco" section is in dark blue.
Holders and representatives
Holders
OncoDNA S.A.
OncoDNA S.A.
Representatives
William R. Samuels COLE-FRIEMAN & MALLON LLP
Technical classification
Nice Classes
Class 9Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable and recorded software in the medical fieldfor cancer diagnosisfor analysis of cancer symptoms and for cancer treatment by integration and interpretation of molecular raw data into actionable clinical actions; downloadable and recorded mobile applications for portable computer devices in the medical fieldfor cancer diagnosisfor analysis of cancer symptoms and for cancer treatment by integration and interpretation of molecular raw data into actionable clinical actions ; downloadable and recorded mobile applications for mobile computing devices in the medical fieldfor cancer diagnosisfor analysis of cancer symptoms and for cancer treatment by integration and interpretation of molecular raw data into actionable clinical actions
Class 42
Scientific research for medical purposes in the field of canceroncology and clinical trials; scientific analysis for medical purposes in the field of canceroncology and clinical trials; genome analysisnamely DNA sequencing of patient's tumors for scientific research purposes; scientific laboratory services; analysis of medical data for scientific research purposes; data encryption services; design and development of computer data base software; design and development of operating software for computer networks and servers; design and development of downloadable mobile computer applications for computer devices; computer system design; information technology servicesnamely creation and design of information directories based on websites for others; IT platform as Service (PaaS) featuring computer software platforms for cancer diagnosis and analysis of cancer symptoms and cancer treatmentin the medical field; electronic data storage
Class 44
Medical services; health servicesnamely health assessment and home health care; therapeutic servicesnamely therapeutic touch services and therapeutic radiological services; medical assistance; medical analysis services for the treatment of peoplenamely cancer diagnosis and/or treatment of cancer; advisory services related to health; hospital services
Publications
History of USPTO decisions and trademark events.
43 publications found
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
03/11/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/09/2026
ES71
TEAS SECTION 71 RECEIVED
11/05/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/05/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/20/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
06/21/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/21/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/21/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/21/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/21/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/21/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/27/2020
FIMP
FINAL DISPOSITION PROCESSED
02/27/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
02/05/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/05/2019
GPNX
NOTIFICATION PROCESSED BY IB
08/23/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/20/2019
PUBO
PUBLISHED FOR OPPOSITION
08/20/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/07/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/07/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/31/2019
ALIE
ASSIGNED TO LIE
07/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/03/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
07/03/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/03/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
07/03/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/03/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/26/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/26/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/26/2019
RFNT
REFUSAL PROCESSED BY IB
06/22/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/05/2019
RFRR
REFUSAL PROCESSED BY MPU
06/05/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/14/2019
CNRT
NON-FINAL ACTION WRITTEN
05/13/2019
MAFR
APPLICATION FILING RECEIPT MAILED
05/10/2019
DOCK
ASSIGNED TO EXAMINER
05/09/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/06/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/02/2019
Continuous trademark protection
Get notified about every new filing that threatens ONCOKDM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.